Sanj K Patel Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

Sanj K Patel is CHAIRMAN & CEO of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 96,674 shares of KNSA, which is worth approximately $2 Million. The most recent transaction as insider was on Mar 20, 2023, when has been sold 12,002 shares (Class A Common Share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 96.7K

21.52% 3M change

53.42% 12M change

Total Value Held $2 Million

Sanj K Patel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 20 2023	BUY Exercise of conversion of derivative security	-	12,002 Added 23.51%	39,038 Class A Common Share
Mar 16 2023	SELL Payment of exercise price or tax liability	$22,106 $11.46 p/Share	1,929 Reduced 6.66%	27,036 Class A Common Share
Mar 16 2023	BUY Exercise of conversion of derivative security	-	6,569 Added 18.49%	28,965 Class A Common Share
Sep 02 2022	SELL Payment of exercise price or tax liability	$22,068 $11.44 p/Share	1,929 Reduced 7.93%	22,396 Class A Common Share
Sep 02 2022	BUY Exercise of conversion of derivative security	-	6,569 Added 21.26%	24,325 Class A Common Share
Mar 21 2022	SELL Payment of exercise price or tax liability	$59,797 $10.98 p/Share	5,446 Reduced 23.47%	17,756 Class A Common Share
Mar 21 2022	BUY Exercise of conversion of derivative security	-	18,555 Added 44.44%	23,202 Class A Common Share
Mar 16 2022	SELL Payment of exercise price or tax liability	$19,470 $10.13 p/Share	1,922 Reduced 29.26%	4,647 Class A Common Share
Mar 16 2022	BUY Exercise of conversion of derivative security	-	6,569 Added 50.0%	6,569 Class A Common Share
Feb 10 2021	SELL Open market or private sale	$36,896 $23.06 p/Share	1,600 Reduced 100.0%	0 Class A Common Shares
Feb 10 2021	BUY Exercise of conversion of derivative security	$2,544 $1.59 p/Share	1,600 Added 50.0%	1,600 Class A Common Shares
Feb 09 2021	SELL Open market or private sale	$470,039 $23.04 p/Share	20,401 Reduced 100.0%	0 Class A Common Shares
Feb 09 2021	BUY Exercise of conversion of derivative security	$32,438 $1.59 p/Share	20,401 Added 50.0%	20,401 Class A Common Shares
Feb 08 2021	SELL Open market or private sale	$113,252 $23.0 p/Share	4,924 Reduced 100.0%	0 Class A Common Shares
Feb 08 2021	BUY Exercise of conversion of derivative security	$7,829 $1.59 p/Share	4,924 Added 50.0%	4,924 Class A Common Shares
Oct 12 2020	SELL Open market or private sale	$3,167,714 $21.02 p/Share	150,700 Reduced 100.0%	0 Class A Common Shares
Oct 12 2020	BUY Exercise of conversion of derivative security	$239,613 $1.59 p/Share	150,700 Added 50.0%	150,700 Class A Common Shares
Oct 09 2020	SELL Open market or private sale	$18,312 $21.0 p/Share	872 Reduced 100.0%	0 Class A Common Shares
Oct 09 2020	BUY Exercise of conversion of derivative security	$1,386 $1.59 p/Share	872 Added 50.0%	872 Class A Common Shares

SKP

Sanj K Patel

CHAIRMAN & CEO

Hamilton, D0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Value

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA

Account